Everett Magann
Concepts (770)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amniotic Fluid | 69 | 2023 | 112 | 13.230 |
Why?
| Pregnancy | 335 | 2023 | 2660 | 12.800 |
Why?
| Ultrasonography, Prenatal | 66 | 2023 | 178 | 10.690 |
Why?
| Pregnancy Complications | 52 | 2023 | 387 | 10.330 |
Why?
| Pregnancy Outcome | 88 | 2023 | 239 | 9.960 |
Why?
| Oligohydramnios | 44 | 2023 | 61 | 6.860 |
Why?
| Cesarean Section | 63 | 2023 | 178 | 6.180 |
Why?
| Obstetrics | 22 | 2022 | 91 | 5.940 |
Why?
| Delivery, Obstetric | 42 | 2020 | 118 | 5.250 |
Why?
| Female | 357 | 2023 | 28710 | 4.960 |
Why?
| Premature Birth | 26 | 2022 | 148 | 4.880 |
Why?
| Gestational Age | 75 | 2023 | 436 | 4.570 |
Why?
| Prenatal Care | 14 | 2023 | 111 | 4.000 |
Why?
| Polyhydramnios | 20 | 2023 | 33 | 3.830 |
Why?
| Telemedicine | 13 | 2023 | 432 | 3.780 |
Why?
| Postpartum Hemorrhage | 12 | 2018 | 32 | 3.570 |
Why?
| Humans | 364 | 2023 | 53625 | 3.540 |
Why?
| Labor Stage, Third | 9 | 2018 | 19 | 3.510 |
Why?
| Adult | 210 | 2022 | 14303 | 3.390 |
Why?
| Placenta | 12 | 2022 | 135 | 3.390 |
Why?
| Obstetric Labor Complications | 19 | 2020 | 33 | 3.300 |
Why?
| Infant, Newborn | 107 | 2023 | 2863 | 3.160 |
Why?
| Uterine Rupture | 5 | 2023 | 12 | 2.870 |
Why?
| Pregnancy, High-Risk | 16 | 2021 | 66 | 2.810 |
Why?
| Fetal Diseases | 8 | 2022 | 54 | 2.770 |
Why?
| Military Personnel | 15 | 2013 | 172 | 2.640 |
Why?
| Pre-Eclampsia | 22 | 2020 | 54 | 2.610 |
Why?
| Hypertension, Pregnancy-Induced | 3 | 2022 | 16 | 2.470 |
Why?
| Twins | 18 | 2014 | 32 | 2.330 |
Why?
| HELLP Syndrome | 25 | 2007 | 25 | 2.320 |
Why?
| Birth Weight | 29 | 2020 | 136 | 2.180 |
Why?
| Labor, Induced | 17 | 2020 | 22 | 2.110 |
Why?
| Prospective Studies | 74 | 2023 | 2571 | 2.080 |
Why?
| Fetal Membranes, Premature Rupture | 6 | 2021 | 20 | 2.080 |
Why?
| Parturition | 8 | 2023 | 59 | 1.810 |
Why?
| Fetal Growth Retardation | 15 | 2016 | 42 | 1.790 |
Why?
| Risk Factors | 54 | 2023 | 3922 | 1.760 |
Why?
| Diabetes, Gestational | 5 | 2021 | 54 | 1.750 |
Why?
| Labor, Obstetric | 13 | 2023 | 41 | 1.710 |
Why?
| Gynecology | 8 | 2022 | 52 | 1.710 |
Why?
| Obstetric Labor, Premature | 18 | 2016 | 42 | 1.700 |
Why?
| Infant, Small for Gestational Age | 12 | 2022 | 34 | 1.630 |
Why?
| Pregnancy, Abdominal | 3 | 2015 | 8 | 1.490 |
Why?
| Surgical Wound Dehiscence | 4 | 2021 | 22 | 1.490 |
Why?
| Pregnancy Complications, Cardiovascular | 8 | 2022 | 35 | 1.480 |
Why?
| Uterine Diseases | 3 | 2020 | 8 | 1.420 |
Why?
| Retrospective Studies | 66 | 2023 | 6313 | 1.420 |
Why?
| Vaginal Birth after Cesarean | 5 | 2023 | 9 | 1.400 |
Why?
| Congenital Abnormalities | 7 | 2021 | 115 | 1.380 |
Why?
| Rural Health Services | 4 | 2016 | 184 | 1.370 |
Why?
| Domestic Violence | 4 | 2012 | 25 | 1.310 |
Why?
| Peripartum Period | 4 | 2022 | 17 | 1.290 |
Why?
| Pregnancy Complications, Infectious | 6 | 2021 | 74 | 1.280 |
Why?
| Young Adult | 39 | 2021 | 4351 | 1.280 |
Why?
| Abortion, Spontaneous | 2 | 2022 | 22 | 1.270 |
Why?
| Fetal Distress | 20 | 2020 | 21 | 1.260 |
Why?
| Ultrasonography, Doppler, Color | 5 | 2019 | 34 | 1.260 |
Why?
| Obesity, Morbid | 3 | 2018 | 87 | 1.250 |
Why?
| Fetal Death | 6 | 2022 | 22 | 1.240 |
Why?
| Pregnancy Trimester, Third | 17 | 2022 | 62 | 1.210 |
Why?
| Fetal Weight | 7 | 2014 | 11 | 1.200 |
Why?
| Fetus | 7 | 2020 | 237 | 1.190 |
Why?
| Dye Dilution Technique | 8 | 2014 | 18 | 1.190 |
Why?
| Postpartum Period | 13 | 2022 | 117 | 1.180 |
Why?
| Ultrasonography | 19 | 2021 | 471 | 1.160 |
Why?
| Pregnancy Complications, Hematologic | 6 | 2021 | 14 | 1.150 |
Why?
| Cervical Ripening | 7 | 2016 | 8 | 1.150 |
Why?
| Uterus | 10 | 2023 | 131 | 1.140 |
Why?
| Parity | 20 | 2020 | 51 | 1.130 |
Why?
| Hypertension | 12 | 2021 | 528 | 1.100 |
Why?
| Dystocia | 9 | 2014 | 10 | 1.090 |
Why?
| Fetal Macrosomia | 12 | 2015 | 21 | 1.080 |
Why?
| Maternal Mortality | 6 | 2020 | 24 | 1.080 |
Why?
| Body Mass Index | 13 | 2020 | 726 | 1.040 |
Why?
| Referral and Consultation | 5 | 2015 | 315 | 1.030 |
Why?
| Adolescent | 54 | 2022 | 6921 | 1.010 |
Why?
| Hemorrhage | 5 | 2022 | 190 | 1.000 |
Why?
| Morbidity | 7 | 2022 | 150 | 1.000 |
Why?
| Pelvic Girdle Pain | 1 | 2023 | 3 | 0.960 |
Why?
| Cervix Uteri | 8 | 2014 | 53 | 0.940 |
Why?
| Mass Screening | 5 | 2012 | 367 | 0.940 |
Why?
| Health Services Accessibility | 4 | 2021 | 441 | 0.910 |
Why?
| Time Factors | 33 | 2018 | 3269 | 0.910 |
Why?
| Adrenal Cortex Hormones | 4 | 2017 | 91 | 0.910 |
Why?
| Adenomyosis | 1 | 2022 | 2 | 0.900 |
Why?
| Pregnancy, Multiple | 5 | 2007 | 20 | 0.900 |
Why?
| Maternal Death | 1 | 2022 | 7 | 0.880 |
Why?
| Prenatal Diagnosis | 7 | 2022 | 107 | 0.880 |
Why?
| Blood Loss, Surgical | 7 | 2012 | 79 | 0.870 |
Why?
| Cystitis | 1 | 2022 | 17 | 0.870 |
Why?
| Rural Population | 4 | 2022 | 603 | 0.860 |
Why?
| Respiratory Distress Syndrome, Newborn | 8 | 2017 | 53 | 0.860 |
Why?
| Health Status Disparities | 2 | 2022 | 230 | 0.830 |
Why?
| Pregnancy Complications, Neoplastic | 2 | 2019 | 21 | 0.830 |
Why?
| Hyperparathyroidism | 1 | 2022 | 50 | 0.830 |
Why?
| Privacy | 1 | 2021 | 18 | 0.830 |
Why?
| Arkansas | 14 | 2022 | 2155 | 0.820 |
Why?
| Surgical Wound Infection | 5 | 2017 | 129 | 0.810 |
Why?
| Postmenopause | 1 | 2022 | 102 | 0.810 |
Why?
| Obesity | 8 | 2020 | 1213 | 0.810 |
Why?
| Communication Barriers | 1 | 2021 | 39 | 0.800 |
Why?
| Education, Medical | 1 | 2022 | 106 | 0.780 |
Why?
| Spinal Cord Injuries | 1 | 2021 | 62 | 0.770 |
Why?
| Torsion Abnormality | 1 | 2020 | 6 | 0.770 |
Why?
| Pregnancy, Twin | 3 | 2014 | 7 | 0.760 |
Why?
| Practice Guidelines as Topic | 10 | 2020 | 497 | 0.760 |
Why?
| Medically Underserved Area | 1 | 2020 | 48 | 0.750 |
Why?
| Umbilical Cord | 1 | 2020 | 35 | 0.750 |
Why?
| Carcinoma, Signet Ring Cell | 1 | 2019 | 14 | 0.740 |
Why?
| Predictive Value of Tests | 29 | 2019 | 1051 | 0.740 |
Why?
| Placenta Diseases | 1 | 2019 | 12 | 0.740 |
Why?
| Fetal Monitoring | 10 | 2013 | 45 | 0.720 |
Why?
| Health Personnel | 2 | 2020 | 250 | 0.720 |
Why?
| Simplexvirus | 1 | 2019 | 12 | 0.710 |
Why?
| Urinary Bladder Calculi | 1 | 2018 | 4 | 0.710 |
Why?
| Disease Management | 1 | 2021 | 186 | 0.710 |
Why?
| Women's Health Services | 1 | 2019 | 18 | 0.700 |
Why?
| Military Medicine | 1 | 2019 | 20 | 0.700 |
Why?
| Herpes Simplex | 1 | 2019 | 26 | 0.700 |
Why?
| Heart Rate, Fetal | 14 | 2016 | 69 | 0.690 |
Why?
| Fetal Mortality | 3 | 2015 | 7 | 0.690 |
Why?
| Dexamethasone | 8 | 2016 | 426 | 0.690 |
Why?
| Uterine Inversion | 1 | 2018 | 2 | 0.680 |
Why?
| Lymphatic Metastasis | 1 | 2019 | 255 | 0.680 |
Why?
| Pregnancy Trimester, Second | 12 | 2020 | 29 | 0.680 |
Why?
| Stillbirth | 4 | 2022 | 30 | 0.670 |
Why?
| Fetal Blood | 11 | 2010 | 66 | 0.670 |
Why?
| Intensive Care Units, Neonatal | 3 | 2015 | 118 | 0.660 |
Why?
| Mississippi | 12 | 2015 | 106 | 0.660 |
Why?
| Women, Working | 2 | 2012 | 7 | 0.660 |
Why?
| Sensitivity and Specificity | 22 | 2017 | 931 | 0.640 |
Why?
| Diverticulum | 1 | 2017 | 22 | 0.630 |
Why?
| Patient Satisfaction | 3 | 2023 | 310 | 0.630 |
Why?
| Internship and Residency | 2 | 2022 | 495 | 0.610 |
Why?
| Apgar Score | 20 | 2018 | 35 | 0.610 |
Why?
| Infant, Premature | 5 | 2015 | 336 | 0.610 |
Why?
| Uterine Retroversion | 1 | 2016 | 3 | 0.610 |
Why?
| Magnesium Sulfate | 7 | 2016 | 13 | 0.600 |
Why?
| Stroke | 1 | 2022 | 499 | 0.600 |
Why?
| Infant Mortality | 10 | 2013 | 70 | 0.600 |
Why?
| Imaging, Three-Dimensional | 2 | 2019 | 176 | 0.600 |
Why?
| Brachial Plexus Neuropathies | 2 | 2014 | 9 | 0.590 |
Why?
| Fish Products | 1 | 2016 | 2 | 0.590 |
Why?
| Pregnancy Complications, Parasitic | 1 | 2016 | 4 | 0.590 |
Why?
| Foodborne Diseases | 1 | 2016 | 10 | 0.580 |
Why?
| Gastroschisis | 1 | 2016 | 41 | 0.580 |
Why?
| Genetic Counseling | 1 | 2016 | 43 | 0.570 |
Why?
| Reproducibility of Results | 14 | 2021 | 1302 | 0.570 |
Why?
| Respiration Disorders | 1 | 2015 | 24 | 0.560 |
Why?
| Blood Pressure | 9 | 2022 | 559 | 0.550 |
Why?
| Hydroxyprogesterones | 4 | 2021 | 8 | 0.550 |
Why?
| Death Certificates | 1 | 2015 | 17 | 0.550 |
Why?
| Genetic Testing | 1 | 2016 | 133 | 0.550 |
Why?
| Birth Certificates | 1 | 2015 | 20 | 0.550 |
Why?
| Tocolysis | 5 | 2015 | 5 | 0.540 |
Why?
| Adenocarcinoma | 1 | 2019 | 429 | 0.540 |
Why?
| Tertiary Care Centers | 2 | 2015 | 88 | 0.540 |
Why?
| Uterine Hemorrhage | 4 | 2021 | 11 | 0.540 |
Why?
| Monitoring, Ambulatory | 1 | 2015 | 11 | 0.530 |
Why?
| Odds Ratio | 9 | 2016 | 614 | 0.530 |
Why?
| Tocolytic Agents | 6 | 2015 | 7 | 0.530 |
Why?
| Randomized Controlled Trials as Topic | 8 | 2021 | 577 | 0.520 |
Why?
| Exercise | 3 | 2009 | 534 | 0.520 |
Why?
| Chorionic Gonadotropin | 1 | 2014 | 15 | 0.520 |
Why?
| Pregnancy Trimester, First | 1 | 2014 | 32 | 0.510 |
Why?
| Spouse Abuse | 3 | 2012 | 19 | 0.510 |
Why?
| Fractures, Bone | 3 | 2014 | 122 | 0.510 |
Why?
| Automobile Driving | 1 | 2014 | 30 | 0.510 |
Why?
| Magnetic Resonance Imaging | 4 | 2022 | 1631 | 0.510 |
Why?
| Lung Neoplasms | 2 | 2019 | 621 | 0.500 |
Why?
| Pregnancy, Prolonged | 5 | 2008 | 8 | 0.500 |
Why?
| Multivariate Analysis | 8 | 2015 | 646 | 0.480 |
Why?
| Catheterization | 2 | 2011 | 103 | 0.480 |
Why?
| Regression Analysis | 12 | 2018 | 466 | 0.480 |
Why?
| Endometritis | 6 | 2010 | 7 | 0.470 |
Why?
| Truth Disclosure | 1 | 2013 | 20 | 0.470 |
Why?
| Posture | 2 | 2005 | 81 | 0.470 |
Why?
| Guideline Adherence | 3 | 2013 | 146 | 0.470 |
Why?
| Algorithms | 4 | 2013 | 696 | 0.460 |
Why?
| Eclampsia | 7 | 2003 | 8 | 0.460 |
Why?
| Prevalence | 9 | 2012 | 1013 | 0.450 |
Why?
| Ideal Body Weight | 1 | 2012 | 7 | 0.440 |
Why?
| Rupture, Spontaneous | 3 | 2022 | 25 | 0.440 |
Why?
| Body Weights and Measures | 1 | 2012 | 19 | 0.440 |
Why?
| Brain Injuries | 1 | 2014 | 180 | 0.440 |
Why?
| United States | 19 | 2021 | 5176 | 0.440 |
Why?
| Pilot Projects | 5 | 2022 | 819 | 0.440 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2013 | 122 | 0.440 |
Why?
| Blood Transfusion | 5 | 2021 | 132 | 0.430 |
Why?
| Acidosis | 7 | 2004 | 35 | 0.420 |
Why?
| Gravidity | 3 | 2020 | 5 | 0.420 |
Why?
| Incidence | 15 | 2020 | 1066 | 0.420 |
Why?
| Contraception | 1 | 2011 | 29 | 0.420 |
Why?
| Intrauterine Devices, Medicated | 1 | 2011 | 1 | 0.410 |
Why?
| Triage | 4 | 2020 | 76 | 0.410 |
Why?
| Levonorgestrel | 1 | 2011 | 4 | 0.410 |
Why?
| Diagnosis, Differential | 7 | 2019 | 1139 | 0.410 |
Why?
| Oxytocin | 2 | 2005 | 18 | 0.410 |
Why?
| Case-Control Studies | 13 | 2018 | 1258 | 0.400 |
Why?
| Cohort Studies | 14 | 2021 | 1553 | 0.400 |
Why?
| Middle Aged | 15 | 2022 | 13218 | 0.400 |
Why?
| Dinoprostone | 4 | 1999 | 54 | 0.400 |
Why?
| Puerperal Disorders | 7 | 2015 | 24 | 0.390 |
Why?
| Aerospace Medicine | 1 | 2010 | 3 | 0.390 |
Why?
| Fluid Therapy | 2 | 2018 | 87 | 0.390 |
Why?
| Clinical Competence | 4 | 2022 | 451 | 0.390 |
Why?
| Terbutaline | 3 | 2008 | 6 | 0.390 |
Why?
| Umbilical Arteries | 11 | 2006 | 22 | 0.380 |
Why?
| Treatment Outcome | 14 | 2022 | 5625 | 0.370 |
Why?
| Amniocentesis | 10 | 2004 | 15 | 0.370 |
Why?
| Battered Women | 1 | 2009 | 4 | 0.360 |
Why?
| Amnion | 5 | 2020 | 11 | 0.360 |
Why?
| Lung | 6 | 2011 | 511 | 0.360 |
Why?
| Reference Values | 9 | 2019 | 376 | 0.350 |
Why?
| Pregnant Women | 3 | 2022 | 77 | 0.350 |
Why?
| Birth Injuries | 5 | 2013 | 9 | 0.350 |
Why?
| Chi-Square Distribution | 9 | 2012 | 328 | 0.340 |
Why?
| Coloring Agents | 4 | 2004 | 84 | 0.340 |
Why?
| Anemia, Sickle Cell | 2 | 2021 | 94 | 0.340 |
Why?
| Bibliometrics | 1 | 2008 | 23 | 0.340 |
Why?
| Fibronectins | 3 | 2011 | 37 | 0.340 |
Why?
| Progestins | 3 | 2014 | 13 | 0.330 |
Why?
| Publishing | 1 | 2008 | 44 | 0.330 |
Why?
| Infant, Newborn, Diseases | 3 | 2014 | 63 | 0.330 |
Why?
| Chorioamnionitis | 4 | 2017 | 18 | 0.320 |
Why?
| Homocysteine | 1 | 2008 | 120 | 0.320 |
Why?
| ROC Curve | 15 | 2016 | 261 | 0.310 |
Why?
| Oxytocics | 3 | 2016 | 7 | 0.300 |
Why?
| Hospitalization | 4 | 2017 | 681 | 0.300 |
Why?
| Hospitals | 2 | 2020 | 171 | 0.300 |
Why?
| Puerperal Infection | 4 | 2005 | 5 | 0.290 |
Why?
| Hypercalcemia | 1 | 2006 | 43 | 0.290 |
Why?
| Brachial Plexus | 5 | 2013 | 13 | 0.290 |
Why?
| Risk Assessment | 9 | 2019 | 1356 | 0.290 |
Why?
| Remote Consultation | 2 | 2017 | 29 | 0.290 |
Why?
| Maternal Age | 6 | 2015 | 44 | 0.290 |
Why?
| Prognosis | 8 | 2018 | 2107 | 0.290 |
Why?
| Nifedipine | 3 | 2015 | 24 | 0.290 |
Why?
| Version, Fetal | 1 | 2005 | 1 | 0.280 |
Why?
| Platelet Count | 10 | 2001 | 72 | 0.280 |
Why?
| Logistic Models | 7 | 2011 | 1002 | 0.280 |
Why?
| Renal Insufficiency | 2 | 2006 | 137 | 0.280 |
Why?
| Lifting | 1 | 2005 | 2 | 0.280 |
Why?
| Hydrogen-Ion Concentration | 13 | 2011 | 196 | 0.280 |
Why?
| Body Weight | 3 | 2013 | 594 | 0.280 |
Why?
| Cerebral Palsy | 3 | 2016 | 43 | 0.270 |
Why?
| Medicaid | 4 | 2021 | 274 | 0.270 |
Why?
| Placenta, Retained | 3 | 2016 | 4 | 0.270 |
Why?
| Noise | 1 | 2005 | 37 | 0.270 |
Why?
| Extraembryonic Membranes | 3 | 2001 | 5 | 0.270 |
Why?
| Exercise Therapy | 2 | 2023 | 123 | 0.270 |
Why?
| Smoking | 4 | 2018 | 559 | 0.260 |
Why?
| Chorion | 1 | 2004 | 1 | 0.260 |
Why?
| Male | 17 | 2022 | 27587 | 0.250 |
Why?
| Intensive Care, Neonatal | 2 | 2003 | 24 | 0.250 |
Why?
| Patient Care Team | 3 | 2021 | 281 | 0.240 |
Why?
| Depression | 3 | 2017 | 600 | 0.240 |
Why?
| Labor Stage, First | 5 | 2015 | 8 | 0.240 |
Why?
| Home Infusion Therapy | 1 | 2003 | 2 | 0.240 |
Why?
| Weight Gain | 4 | 2013 | 239 | 0.240 |
Why?
| Chorionic Villi | 2 | 2019 | 3 | 0.230 |
Why?
| Blood Volume | 2 | 2018 | 69 | 0.230 |
Why?
| Confidence Intervals | 5 | 2016 | 169 | 0.230 |
Why?
| International Classification of Diseases | 2 | 2015 | 65 | 0.230 |
Why?
| Marital Status | 2 | 2009 | 23 | 0.230 |
Why?
| Pubic Symphysis | 2 | 2015 | 4 | 0.220 |
Why?
| Hospitals, Military | 2 | 2014 | 7 | 0.220 |
Why?
| Intrauterine Devices | 2 | 2012 | 5 | 0.220 |
Why?
| Polymorphism, Single Nucleotide | 4 | 2010 | 572 | 0.220 |
Why?
| Energy Metabolism | 2 | 2013 | 318 | 0.220 |
Why?
| Mandatory Reporting | 2 | 2012 | 14 | 0.220 |
Why?
| Quality of Life | 2 | 2023 | 906 | 0.220 |
Why?
| Hospitals, Teaching | 2 | 2020 | 63 | 0.220 |
Why?
| Embryo Implantation | 1 | 2002 | 18 | 0.220 |
Why?
| Acute Disease | 2 | 2022 | 401 | 0.210 |
Why?
| Mothers | 2 | 2017 | 241 | 0.210 |
Why?
| Anti-Inflammatory Agents | 2 | 2000 | 177 | 0.210 |
Why?
| Licensure | 1 | 2021 | 16 | 0.210 |
Why?
| Health Insurance Portability and Accountability Act | 1 | 2021 | 13 | 0.210 |
Why?
| Term Birth | 3 | 2015 | 21 | 0.210 |
Why?
| South Carolina | 3 | 2015 | 43 | 0.210 |
Why?
| Technology | 1 | 2021 | 19 | 0.210 |
Why?
| Reproductive Health | 1 | 2021 | 11 | 0.200 |
Why?
| Uterine Contraction | 3 | 2008 | 41 | 0.200 |
Why?
| Tissue Plasminogen Activator | 1 | 2022 | 120 | 0.200 |
Why?
| Risk Adjustment | 1 | 2021 | 30 | 0.200 |
Why?
| Hysterectomy | 4 | 2021 | 87 | 0.200 |
Why?
| Antithrombin Proteins | 1 | 2020 | 1 | 0.200 |
Why?
| Prolapse | 1 | 2020 | 7 | 0.200 |
Why?
| Fatal Outcome | 2 | 2019 | 225 | 0.200 |
Why?
| Placenta Accreta | 1 | 2021 | 25 | 0.200 |
Why?
| Maternal Health Services | 1 | 2021 | 31 | 0.200 |
Why?
| Biophysical Phenomena | 3 | 2014 | 20 | 0.190 |
Why?
| Sleep | 1 | 2002 | 188 | 0.190 |
Why?
| Probability | 6 | 2008 | 183 | 0.190 |
Why?
| Patient Care Planning | 1 | 2020 | 81 | 0.190 |
Why?
| Surrogate Mothers | 1 | 2019 | 4 | 0.180 |
Why?
| Uterine Cervical Incompetence | 2 | 2011 | 2 | 0.180 |
Why?
| Cerclage, Cervical | 2 | 2011 | 7 | 0.180 |
Why?
| Cross-Sectional Studies | 4 | 2017 | 1664 | 0.180 |
Why?
| L-Lactate Dehydrogenase | 7 | 2001 | 84 | 0.180 |
Why?
| Chest Pain | 1 | 2019 | 67 | 0.180 |
Why?
| Dyspnea | 1 | 2019 | 80 | 0.180 |
Why?
| Quality Improvement | 1 | 2022 | 238 | 0.180 |
Why?
| Abdominal Pain | 1 | 2020 | 75 | 0.180 |
Why?
| Postoperative Complications | 7 | 2017 | 1054 | 0.180 |
Why?
| Honduras | 1 | 2019 | 1 | 0.180 |
Why?
| Guatemala | 1 | 2019 | 4 | 0.180 |
Why?
| Colombia | 1 | 2019 | 13 | 0.180 |
Why?
| Acyclovir | 1 | 2019 | 10 | 0.180 |
Why?
| Contraception Behavior | 1 | 2019 | 12 | 0.180 |
Why?
| Office Visits | 2 | 2013 | 48 | 0.180 |
Why?
| Anticonvulsants | 2 | 2016 | 132 | 0.180 |
Why?
| Lithotripsy, Laser | 1 | 2018 | 7 | 0.180 |
Why?
| Infant, Premature, Diseases | 3 | 2020 | 92 | 0.170 |
Why?
| Australia | 3 | 2012 | 87 | 0.170 |
Why?
| Tomography, X-Ray Computed | 3 | 2022 | 1197 | 0.170 |
Why?
| Mental Health Services | 1 | 2022 | 245 | 0.170 |
Why?
| Obstetric Surgical Procedures | 1 | 2018 | 3 | 0.170 |
Why?
| Cell Adhesion Molecules | 1 | 2019 | 83 | 0.170 |
Why?
| Medical Records | 4 | 2014 | 95 | 0.170 |
Why?
| Internet | 1 | 2021 | 277 | 0.170 |
Why?
| Critical Illness | 1 | 2021 | 333 | 0.170 |
Why?
| Child | 2 | 2023 | 7231 | 0.170 |
Why?
| Vaginosis, Bacterial | 2 | 2011 | 14 | 0.170 |
Why?
| Wounds and Injuries | 3 | 2009 | 317 | 0.170 |
Why?
| Linear Models | 7 | 2021 | 320 | 0.160 |
Why?
| Infant | 5 | 2022 | 3765 | 0.160 |
Why?
| Fetal Development | 2 | 2016 | 62 | 0.160 |
Why?
| Seasons | 1 | 1998 | 98 | 0.160 |
Why?
| Early Diagnosis | 1 | 2018 | 95 | 0.160 |
Why?
| Temperature | 2 | 1998 | 179 | 0.160 |
Why?
| Glucose Tolerance Test | 2 | 2010 | 76 | 0.160 |
Why?
| Medical Laboratory Personnel | 1 | 1997 | 5 | 0.160 |
Why?
| Age Factors | 3 | 2011 | 1213 | 0.160 |
Why?
| Pyelonephritis | 1 | 2017 | 5 | 0.160 |
Why?
| Actinomyces | 1 | 2017 | 9 | 0.160 |
Why?
| Proportional Hazards Models | 2 | 2015 | 433 | 0.160 |
Why?
| Actinomycosis | 1 | 2017 | 10 | 0.160 |
Why?
| Emergency Service, Hospital | 1 | 2022 | 527 | 0.160 |
Why?
| Antiviral Agents | 1 | 2019 | 188 | 0.160 |
Why?
| Emergency Medical Services | 2 | 2012 | 126 | 0.160 |
Why?
| Indomethacin | 2 | 2015 | 38 | 0.150 |
Why?
| Self-Injurious Behavior | 1 | 2017 | 29 | 0.150 |
Why?
| Professional Competence | 1 | 1997 | 47 | 0.150 |
Why?
| Aged | 3 | 2022 | 10132 | 0.150 |
Why?
| Malpractice | 2 | 2008 | 16 | 0.150 |
Why?
| Severity of Illness Index | 7 | 2010 | 1083 | 0.150 |
Why?
| Fetal Organ Maturity | 5 | 2000 | 10 | 0.150 |
Why?
| Telephone | 2 | 2017 | 78 | 0.150 |
Why?
| Hematocrit | 3 | 2012 | 53 | 0.150 |
Why?
| Systole | 1 | 2016 | 75 | 0.150 |
Why?
| Brain Waves | 1 | 2016 | 23 | 0.150 |
Why?
| Patient Care Management | 1 | 2016 | 21 | 0.150 |
Why?
| Symptom Assessment | 1 | 2016 | 41 | 0.150 |
Why?
| Reactive Oxygen Species | 1 | 2019 | 459 | 0.150 |
Why?
| Antioxidants | 1 | 2019 | 282 | 0.150 |
Why?
| Intestinal Diseases, Parasitic | 1 | 2016 | 5 | 0.150 |
Why?
| Trial of Labor | 5 | 2008 | 5 | 0.150 |
Why?
| Hospitals, University | 3 | 2014 | 95 | 0.150 |
Why?
| Suicidal Ideation | 1 | 2017 | 98 | 0.140 |
Why?
| Colposcopy | 1 | 2016 | 20 | 0.140 |
Why?
| Socioeconomic Factors | 2 | 2016 | 636 | 0.140 |
Why?
| Pubic Symphysis Diastasis | 1 | 2015 | 2 | 0.140 |
Why?
| Clavicle | 2 | 2013 | 5 | 0.140 |
Why?
| Hospitals, Community | 2 | 2014 | 22 | 0.140 |
Why?
| Humeral Fractures | 2 | 2013 | 10 | 0.140 |
Why?
| Kidney | 1 | 2021 | 823 | 0.140 |
Why?
| Twins, Dizygotic | 1 | 1995 | 7 | 0.140 |
Why?
| Urologic Diseases | 1 | 2015 | 11 | 0.140 |
Why?
| Employment | 1 | 1996 | 102 | 0.140 |
Why?
| Magnetoencephalography | 1 | 2016 | 128 | 0.140 |
Why?
| Language Development Disorders | 1 | 2015 | 18 | 0.130 |
Why?
| Neuroprotective Agents | 1 | 2016 | 131 | 0.130 |
Why?
| Pregnancy in Diabetics | 4 | 2010 | 25 | 0.130 |
Why?
| Humidity | 1 | 1995 | 7 | 0.130 |
Why?
| Drug Implants | 2 | 2011 | 35 | 0.130 |
Why?
| Animal Assisted Therapy | 1 | 2014 | 3 | 0.130 |
Why?
| Episiotomy | 1 | 2014 | 8 | 0.130 |
Why?
| Follow-Up Studies | 7 | 2017 | 2370 | 0.130 |
Why?
| Insulin | 2 | 2007 | 535 | 0.130 |
Why?
| Sheep | 1 | 2014 | 94 | 0.130 |
Why?
| Southwestern United States | 1 | 2014 | 24 | 0.130 |
Why?
| Naval Medicine | 2 | 2009 | 5 | 0.130 |
Why?
| Progesterone | 1 | 2014 | 90 | 0.130 |
Why?
| Louisiana | 1 | 2014 | 59 | 0.130 |
Why?
| Safety | 1 | 2015 | 95 | 0.130 |
Why?
| Southeastern United States | 1 | 2014 | 58 | 0.130 |
Why?
| Misoprostol | 2 | 2016 | 4 | 0.130 |
Why?
| Calcium Channel Blockers | 1 | 1994 | 70 | 0.120 |
Why?
| Physician-Patient Relations | 2 | 2013 | 155 | 0.120 |
Why?
| Clinical Protocols | 2 | 2012 | 123 | 0.120 |
Why?
| Stress, Psychological | 3 | 2008 | 281 | 0.120 |
Why?
| Estradiol | 1 | 1995 | 242 | 0.120 |
Why?
| Academic Medical Centers | 1 | 2014 | 146 | 0.120 |
Why?
| Xylenes | 1 | 1993 | 3 | 0.120 |
Why?
| Health Care Costs | 1 | 2015 | 170 | 0.120 |
Why?
| Insulin-Like Growth Factor II | 2 | 2010 | 28 | 0.120 |
Why?
| Premedication | 1 | 1993 | 18 | 0.120 |
Why?
| Cefazolin | 1 | 1993 | 11 | 0.120 |
Why?
| Healthy People Programs | 1 | 2013 | 4 | 0.120 |
Why?
| Cost-Benefit Analysis | 1 | 2015 | 290 | 0.120 |
Why?
| Curettage | 1 | 1993 | 16 | 0.120 |
Why?
| Brain Diseases | 2 | 2005 | 83 | 0.120 |
Why?
| Depression, Postpartum | 1 | 2013 | 40 | 0.120 |
Why?
| Oxidative Stress | 1 | 2019 | 916 | 0.120 |
Why?
| Uterine Cervical Neoplasms | 1 | 2016 | 273 | 0.120 |
Why?
| Analysis of Variance | 7 | 2001 | 659 | 0.120 |
Why?
| Placenta Previa | 1 | 1993 | 6 | 0.120 |
Why?
| Anti-Infective Agents, Local | 1 | 1993 | 25 | 0.120 |
Why?
| Intraoperative Care | 1 | 1993 | 58 | 0.120 |
Why?
| Counseling | 1 | 2014 | 150 | 0.120 |
Why?
| Adnexa Uteri | 1 | 2012 | 1 | 0.120 |
Why?
| Image Enhancement | 1 | 2013 | 58 | 0.120 |
Why?
| Peritoneum | 1 | 2012 | 12 | 0.110 |
Why?
| Data Collection | 2 | 2012 | 330 | 0.110 |
Why?
| Abdominal Wall | 1 | 2012 | 10 | 0.110 |
Why?
| Digestive System | 1 | 2012 | 19 | 0.110 |
Why?
| Retroperitoneal Space | 1 | 2012 | 24 | 0.110 |
Why?
| Patient Admission | 2 | 2005 | 79 | 0.110 |
Why?
| Government Agencies | 1 | 2012 | 14 | 0.110 |
Why?
| Abdomen | 4 | 2006 | 81 | 0.110 |
Why?
| Birth Rate | 1 | 2012 | 4 | 0.110 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2015 | 237 | 0.110 |
Why?
| Hemoglobins | 1 | 2013 | 126 | 0.110 |
Why?
| Local Government | 1 | 2012 | 25 | 0.110 |
Why?
| Anxiety | 1 | 2014 | 276 | 0.110 |
Why?
| Return to Work | 1 | 2012 | 17 | 0.110 |
Why?
| Reference Standards | 1 | 2012 | 67 | 0.110 |
Why?
| Patient Care | 1 | 2012 | 57 | 0.110 |
Why?
| Administration, Intravaginal | 4 | 2014 | 8 | 0.110 |
Why?
| Desogestrel | 1 | 2011 | 2 | 0.110 |
Why?
| Urination | 1 | 2011 | 18 | 0.110 |
Why?
| Contraceptive Agents, Female | 1 | 2011 | 5 | 0.110 |
Why?
| Reproductive History | 1 | 2011 | 4 | 0.110 |
Why?
| Family Practice | 1 | 2012 | 65 | 0.110 |
Why?
| Breech Presentation | 2 | 2005 | 2 | 0.110 |
Why?
| Drug Eruptions | 1 | 2011 | 15 | 0.110 |
Why?
| Traction | 1 | 2011 | 6 | 0.110 |
Why?
| Motor Activity | 1 | 2013 | 259 | 0.110 |
Why?
| Osmolar Concentration | 1 | 2011 | 84 | 0.110 |
Why?
| Personal Satisfaction | 1 | 2012 | 87 | 0.100 |
Why?
| Emotions | 1 | 2013 | 175 | 0.100 |
Why?
| Labor Stage, Second | 2 | 2008 | 3 | 0.100 |
Why?
| Deglutition | 1 | 2011 | 37 | 0.100 |
Why?
| Surgical Sponges | 1 | 2011 | 7 | 0.100 |
Why?
| Attitude of Health Personnel | 3 | 2012 | 419 | 0.100 |
Why?
| Qualitative Research | 1 | 2013 | 343 | 0.100 |
Why?
| Guidelines as Topic | 1 | 2012 | 123 | 0.100 |
Why?
| Fetal Proteins | 1 | 2011 | 4 | 0.100 |
Why?
| Cesarean Section, Repeat | 2 | 2003 | 6 | 0.100 |
Why?
| 17-alpha-Hydroxyprogesterone | 1 | 2011 | 1 | 0.100 |
Why?
| Hypoxia-Ischemia, Brain | 2 | 2010 | 69 | 0.100 |
Why?
| Medical Errors | 1 | 2011 | 36 | 0.100 |
Why?
| Metronidazole | 1 | 2011 | 30 | 0.100 |
Why?
| Genomic Imprinting | 2 | 2007 | 12 | 0.100 |
Why?
| Periodicals as Topic | 2 | 2010 | 69 | 0.100 |
Why?
| Infusions, Intravenous | 2 | 2003 | 231 | 0.100 |
Why?
| Weight-Bearing | 1 | 2011 | 64 | 0.100 |
Why?
| Receptor, IGF Type 2 | 1 | 2010 | 9 | 0.100 |
Why?
| Communication | 1 | 2013 | 273 | 0.100 |
Why?
| Hemostasis, Surgical | 2 | 2005 | 12 | 0.100 |
Why?
| RNA, Untranslated | 1 | 2010 | 16 | 0.100 |
Why?
| Hypersensitivity | 1 | 2011 | 76 | 0.100 |
Why?
| Hemodynamics | 1 | 2012 | 251 | 0.100 |
Why?
| Aviation | 1 | 2010 | 7 | 0.100 |
Why?
| Foreign Bodies | 1 | 2011 | 64 | 0.100 |
Why?
| Appendicitis | 2 | 2009 | 78 | 0.100 |
Why?
| Betamethasone | 2 | 2016 | 5 | 0.100 |
Why?
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2010 | 4 | 0.100 |
Why?
| Longitudinal Studies | 2 | 2011 | 746 | 0.100 |
Why?
| Haplotypes | 2 | 2007 | 101 | 0.100 |
Why?
| Length of Stay | 3 | 2021 | 690 | 0.100 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 560 | 0.090 |
Why?
| Monitoring, Physiologic | 1 | 2011 | 139 | 0.090 |
Why?
| Fetal Movement | 2 | 2000 | 23 | 0.090 |
Why?
| Anti-Infective Agents | 1 | 2011 | 104 | 0.090 |
Why?
| Heart Diseases | 2 | 2005 | 228 | 0.090 |
Why?
| Pelvis | 2 | 2015 | 76 | 0.090 |
Why?
| Physical Examination | 3 | 2003 | 97 | 0.090 |
Why?
| Perinatal Care | 2 | 2020 | 24 | 0.090 |
Why?
| Cardiac Complexes, Premature | 1 | 2009 | 4 | 0.090 |
Why?
| Clothing | 1 | 2009 | 6 | 0.090 |
Why?
| Child, Preschool | 2 | 2015 | 4126 | 0.090 |
Why?
| Meconium | 2 | 1999 | 5 | 0.090 |
Why?
| Exercise Tolerance | 1 | 2009 | 43 | 0.090 |
Why?
| Hemangioendothelioma, Epithelioid | 1 | 2009 | 2 | 0.090 |
Why?
| Education, Medical, Continuing | 1 | 2010 | 82 | 0.090 |
Why?
| Suppositories | 3 | 2015 | 4 | 0.090 |
Why?
| Social Perception | 1 | 2009 | 34 | 0.090 |
Why?
| Physician's Role | 1 | 2009 | 58 | 0.090 |
Why?
| Medical History Taking | 1 | 2009 | 51 | 0.090 |
Why?
| Patient Preference | 1 | 2009 | 40 | 0.090 |
Why?
| Anthropometry | 2 | 2006 | 98 | 0.090 |
Why?
| Physicians | 2 | 2012 | 254 | 0.090 |
Why?
| Attitude to Death | 1 | 2008 | 11 | 0.090 |
Why?
| Research Design | 2 | 2008 | 374 | 0.090 |
Why?
| Meta-Analysis as Topic | 1 | 2008 | 39 | 0.090 |
Why?
| Emergency Treatment | 2 | 2008 | 32 | 0.080 |
Why?
| Evidence-Based Medicine | 2 | 2009 | 285 | 0.080 |
Why?
| Pregnancy, Ectopic | 1 | 2008 | 5 | 0.080 |
Why?
| Cardiotocography | 2 | 2005 | 10 | 0.080 |
Why?
| Surgical Procedures, Operative | 1 | 2009 | 80 | 0.080 |
Why?
| Forecasting | 2 | 2007 | 163 | 0.080 |
Why?
| Asphyxia Neonatorum | 2 | 2010 | 9 | 0.080 |
Why?
| Fecal Incontinence | 1 | 2008 | 12 | 0.080 |
Why?
| Creatinine | 2 | 2006 | 172 | 0.080 |
Why?
| Societies, Medical | 2 | 2006 | 194 | 0.080 |
Why?
| Constipation | 1 | 2008 | 32 | 0.080 |
Why?
| p-Aminohippuric Acid | 2 | 1999 | 12 | 0.080 |
Why?
| Spectrophotometry | 2 | 1999 | 37 | 0.080 |
Why?
| Administration, Intravenous | 2 | 2020 | 78 | 0.080 |
Why?
| Perinatal Mortality | 2 | 2020 | 3 | 0.080 |
Why?
| Genetic Diseases, Inborn | 2 | 1999 | 26 | 0.080 |
Why?
| Brain | 1 | 2016 | 1409 | 0.080 |
Why?
| Breast Feeding | 1 | 2009 | 191 | 0.080 |
Why?
| Double-Blind Method | 3 | 2020 | 743 | 0.080 |
Why?
| Abortion, Induced | 2 | 1998 | 20 | 0.080 |
Why?
| Nurse's Role | 1 | 2007 | 92 | 0.080 |
Why?
| Sepsis | 3 | 2009 | 242 | 0.080 |
Why?
| Body Size | 1 | 2007 | 30 | 0.080 |
Why?
| Antacids | 1 | 2006 | 13 | 0.080 |
Why?
| Workload | 1 | 2006 | 51 | 0.070 |
Why?
| Thinness | 1 | 2006 | 56 | 0.070 |
Why?
| Ludwig's Angina | 1 | 2006 | 1 | 0.070 |
Why?
| Gastroesophageal Reflux | 1 | 2006 | 51 | 0.070 |
Why?
| Drug Administration Schedule | 4 | 2011 | 411 | 0.070 |
Why?
| Thrombocytopenia | 4 | 2000 | 98 | 0.070 |
Why?
| Mesothelioma | 1 | 2005 | 19 | 0.070 |
Why?
| Blood Gas Monitoring, Transcutaneous | 1 | 2005 | 8 | 0.070 |
Why?
| Acid-Base Imbalance | 1 | 2005 | 1 | 0.070 |
Why?
| Uterine Neoplasms | 1 | 2005 | 66 | 0.070 |
Why?
| Gene Frequency | 3 | 2010 | 119 | 0.070 |
Why?
| Leptin | 1 | 2007 | 166 | 0.070 |
Why?
| Analgesics | 1 | 2006 | 106 | 0.070 |
Why?
| Colonic Pseudo-Obstruction | 1 | 2004 | 2 | 0.070 |
Why?
| Pain, Postoperative | 1 | 2006 | 165 | 0.070 |
Why?
| Liver Neoplasms | 1 | 2009 | 350 | 0.070 |
Why?
| Hypoglycemia | 1 | 2005 | 61 | 0.070 |
Why?
| Vagina | 2 | 2011 | 46 | 0.070 |
Why?
| Antibiotic Prophylaxis | 1 | 2005 | 68 | 0.070 |
Why?
| Workplace | 1 | 2005 | 103 | 0.060 |
Why?
| Statistics, Nonparametric | 3 | 2011 | 236 | 0.060 |
Why?
| False Positive Reactions | 3 | 2007 | 67 | 0.060 |
Why?
| Proteins | 1 | 2007 | 391 | 0.060 |
Why?
| Calcium | 1 | 2006 | 435 | 0.060 |
Why?
| Biophysics | 2 | 2004 | 20 | 0.060 |
Why?
| Pelvic Inflammatory Disease | 1 | 2004 | 11 | 0.060 |
Why?
| Thrombophlebitis | 1 | 2004 | 29 | 0.060 |
Why?
| Palliative Care | 1 | 2006 | 187 | 0.060 |
Why?
| Urogenital System | 1 | 2003 | 6 | 0.060 |
Why?
| Pregnancy Trimesters | 2 | 2017 | 10 | 0.060 |
Why?
| Swimming | 1 | 2003 | 30 | 0.060 |
Why?
| Glycoproteins | 1 | 2004 | 137 | 0.060 |
Why?
| Infusion Pumps | 1 | 2003 | 14 | 0.060 |
Why?
| Platelet Storage Pool Deficiency | 1 | 2003 | 1 | 0.060 |
Why?
| Injections, Subcutaneous | 1 | 2003 | 60 | 0.060 |
Why?
| Outpatients | 1 | 2004 | 123 | 0.060 |
Why?
| Recurrence | 2 | 2003 | 695 | 0.060 |
Why?
| Sphingomyelins | 2 | 2000 | 8 | 0.060 |
Why?
| Propionates | 1 | 2003 | 28 | 0.060 |
Why?
| Phosphatidylcholines | 2 | 2000 | 34 | 0.060 |
Why?
| Autopsy | 1 | 2022 | 49 | 0.060 |
Why?
| Multiple Organ Failure | 1 | 2003 | 54 | 0.060 |
Why?
| Emergencies | 2 | 2021 | 91 | 0.060 |
Why?
| Hospital Costs | 1 | 2003 | 86 | 0.060 |
Why?
| Tissue Expansion | 1 | 2002 | 4 | 0.060 |
Why?
| Blood Pressure Determination | 2 | 2003 | 52 | 0.060 |
Why?
| Aspartate Aminotransferases | 3 | 1999 | 59 | 0.060 |
Why?
| Disseminated Intravascular Coagulation | 2 | 1999 | 8 | 0.050 |
Why?
| Surgical Instruments | 1 | 2002 | 35 | 0.050 |
Why?
| Anti-Bacterial Agents | 2 | 2005 | 803 | 0.050 |
Why?
| Health Promotion | 1 | 2005 | 307 | 0.050 |
Why?
| Immunization, Passive | 1 | 2021 | 35 | 0.050 |
Why?
| Kidney Diseases | 1 | 2005 | 284 | 0.050 |
Why?
| Contrast Media | 1 | 2003 | 218 | 0.050 |
Why?
| Wound Healing | 2 | 1994 | 228 | 0.050 |
Why?
| Risk | 3 | 2013 | 343 | 0.050 |
Why?
| Proteinuria | 3 | 1999 | 53 | 0.050 |
Why?
| Administration, Oral | 2 | 2015 | 466 | 0.050 |
Why?
| Seizures | 1 | 2003 | 200 | 0.050 |
Why?
| Dose-Response Relationship, Drug | 3 | 2006 | 1509 | 0.050 |
Why?
| Leukocytosis | 1 | 2000 | 14 | 0.050 |
Why?
| Respiration | 1 | 2000 | 93 | 0.050 |
Why?
| Shoulder | 2 | 2008 | 37 | 0.050 |
Why?
| Models, Theoretical | 2 | 1999 | 195 | 0.050 |
Why?
| Intensive Care Units | 1 | 2021 | 225 | 0.050 |
Why?
| Sodium Chloride | 2 | 1998 | 67 | 0.050 |
Why?
| Blood Gas Analysis | 2 | 2003 | 31 | 0.050 |
Why?
| Embryo Transfer | 1 | 2019 | 21 | 0.050 |
Why?
| Disorders of Sex Development | 1 | 1999 | 7 | 0.050 |
Why?
| Mental Health | 1 | 2022 | 229 | 0.050 |
Why?
| Fetal Hemoglobin | 1 | 1999 | 7 | 0.040 |
Why?
| Erythrocyte Count | 1 | 1999 | 6 | 0.040 |
Why?
| Fetomaternal Transfusion | 1 | 1999 | 3 | 0.040 |
Why?
| Placentation | 1 | 2019 | 11 | 0.040 |
Why?
| Lung Diseases | 1 | 2000 | 85 | 0.040 |
Why?
| Trophoblasts | 1 | 2019 | 30 | 0.040 |
Why?
| Palpation | 1 | 1998 | 7 | 0.040 |
Why?
| Weather | 1 | 1998 | 7 | 0.040 |
Why?
| Labor Presentation | 1 | 1998 | 1 | 0.040 |
Why?
| Obstetrical Forceps | 2 | 2015 | 5 | 0.040 |
Why?
| Dilatation and Curettage | 2 | 1998 | 2 | 0.040 |
Why?
| Genotype | 2 | 2010 | 614 | 0.040 |
Why?
| Recombinant Proteins | 1 | 2020 | 576 | 0.040 |
Why?
| Gels | 1 | 1998 | 19 | 0.040 |
Why?
| Alanine Transaminase | 2 | 1999 | 148 | 0.040 |
Why?
| Gaucher Disease | 1 | 1998 | 17 | 0.040 |
Why?
| Databases, Factual | 2 | 2015 | 693 | 0.040 |
Why?
| Skull | 2 | 1995 | 75 | 0.040 |
Why?
| Animals | 1 | 2014 | 14481 | 0.040 |
Why?
| Costs and Cost Analysis | 1 | 1998 | 110 | 0.040 |
Why?
| Carboprost | 1 | 1998 | 1 | 0.040 |
Why?
| Abortifacient Agents, Nonsteroidal | 1 | 1998 | 2 | 0.040 |
Why?
| Education, Medical, Graduate | 1 | 2020 | 224 | 0.040 |
Why?
| Cerebral Hemorrhage | 2 | 2014 | 103 | 0.040 |
Why?
| Treatment Failure | 2 | 2009 | 141 | 0.040 |
Why?
| Georgia | 1 | 2017 | 40 | 0.040 |
Why?
| Patient Discharge | 1 | 2000 | 353 | 0.040 |
Why?
| Critical Care | 1 | 2000 | 229 | 0.040 |
Why?
| Chronic Disease | 2 | 2003 | 622 | 0.040 |
Why?
| Evaluation Studies as Topic | 2 | 1998 | 104 | 0.040 |
Why?
| APACHE | 1 | 2017 | 24 | 0.040 |
Why?
| Embryonic and Fetal Development | 1 | 1997 | 21 | 0.040 |
Why?
| Indicator Dilution Techniques | 2 | 1997 | 11 | 0.040 |
Why?
| Self Care | 1 | 1998 | 141 | 0.040 |
Why?
| Injections, Intramuscular | 2 | 2009 | 51 | 0.040 |
Why?
| Isotonic Solutions | 1 | 1996 | 21 | 0.040 |
Why?
| Nicotine | 1 | 2018 | 203 | 0.040 |
Why?
| Water-Electrolyte Imbalance | 1 | 1996 | 16 | 0.040 |
Why?
| Therapeutic Irrigation | 2 | 1993 | 27 | 0.040 |
Why?
| Suture Techniques | 2 | 1994 | 74 | 0.040 |
Why?
| Chlorides | 1 | 1996 | 56 | 0.040 |
Why?
| Transportation | 1 | 2016 | 31 | 0.040 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2018 | 199 | 0.040 |
Why?
| Psychometrics | 1 | 2017 | 245 | 0.040 |
Why?
| Dinoprost | 1 | 1995 | 12 | 0.040 |
Why?
| Cephalopelvic Disproportion | 1 | 2015 | 2 | 0.040 |
Why?
| Rupture | 1 | 2015 | 32 | 0.040 |
Why?
| Psychiatric Status Rating Scales | 1 | 2017 | 355 | 0.040 |
Why?
| Flow Cytometry | 1 | 1999 | 551 | 0.040 |
Why?
| Florida | 1 | 1995 | 58 | 0.030 |
Why?
| Occupations | 1 | 1995 | 21 | 0.030 |
Why?
| Fracture Fixation | 1 | 2015 | 24 | 0.030 |
Why?
| Urogenital Abnormalities | 1 | 2015 | 18 | 0.030 |
Why?
| Depressive Disorder, Major | 1 | 2017 | 162 | 0.030 |
Why?
| Administration, Rectal | 1 | 2015 | 10 | 0.030 |
Why?
| Teratoma | 1 | 1995 | 24 | 0.030 |
Why?
| Hematologic Tests | 1 | 1995 | 12 | 0.030 |
Why?
| Program Evaluation | 1 | 2017 | 385 | 0.030 |
Why?
| Liver Function Tests | 1 | 1995 | 44 | 0.030 |
Why?
| Smoking Cessation | 1 | 2018 | 311 | 0.030 |
Why?
| Sexual Behavior | 1 | 2016 | 132 | 0.030 |
Why?
| Cervical Length Measurement | 1 | 2014 | 1 | 0.030 |
Why?
| Discriminant Analysis | 1 | 1994 | 34 | 0.030 |
Why?
| Interleukin-8 | 1 | 1994 | 97 | 0.030 |
Why?
| Radiography | 1 | 2015 | 525 | 0.030 |
Why?
| Enterocolitis, Necrotizing | 1 | 2014 | 37 | 0.030 |
Why?
| Stress, Physiological | 1 | 1995 | 200 | 0.030 |
Why?
| Antibodies, Monoclonal | 1 | 1999 | 551 | 0.030 |
Why?
| Drug Administration Routes | 1 | 2013 | 14 | 0.030 |
Why?
| Glucocorticoids | 1 | 2016 | 277 | 0.030 |
Why?
| Povidone-Iodine | 1 | 1993 | 6 | 0.030 |
Why?
| Bronchopulmonary Dysplasia | 1 | 2014 | 65 | 0.030 |
Why?
| Biometry | 3 | 2000 | 27 | 0.030 |
Why?
| Interleukin-6 | 1 | 1994 | 311 | 0.030 |
Why?
| Maternal Welfare | 2 | 2004 | 12 | 0.030 |
Why?
| New Zealand | 1 | 2012 | 18 | 0.030 |
Why?
| Leukocyte Count | 2 | 2004 | 79 | 0.030 |
Why?
| Ascites | 1 | 1992 | 27 | 0.030 |
Why?
| Auscultation | 1 | 2012 | 9 | 0.030 |
Why?
| Self Report | 1 | 2013 | 209 | 0.030 |
Why?
| Canada | 1 | 2012 | 105 | 0.030 |
Why?
| Health Care Surveys | 1 | 2012 | 196 | 0.030 |
Why?
| Disease Progression | 1 | 1995 | 907 | 0.030 |
Why?
| Oximetry | 1 | 2012 | 61 | 0.030 |
Why?
| Patient Safety | 1 | 2012 | 124 | 0.030 |
Why?
| Brain Neoplasms | 1 | 1995 | 270 | 0.030 |
Why?
| Area Under Curve | 1 | 2011 | 208 | 0.020 |
Why?
| Chromogranins | 1 | 2010 | 5 | 0.020 |
Why?
| Models, Statistical | 1 | 2012 | 255 | 0.020 |
Why?
| Health Planning Guidelines | 1 | 2010 | 12 | 0.020 |
Why?
| Inheritance Patterns | 1 | 2010 | 23 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 322 | 0.020 |
Why?
| Models, Biological | 1 | 1994 | 836 | 0.020 |
Why?
| Uric Acid | 2 | 1999 | 31 | 0.020 |
Why?
| Medical Informatics | 1 | 2010 | 52 | 0.020 |
Why?
| Nausea | 2 | 1999 | 53 | 0.020 |
Why?
| Systemic Inflammatory Response Syndrome | 1 | 2009 | 49 | 0.020 |
Why?
| Data Interpretation, Statistical | 1 | 2010 | 178 | 0.020 |
Why?
| Appendectomy | 1 | 2009 | 42 | 0.020 |
Why?
| Western Australia | 1 | 2008 | 6 | 0.020 |
Why?
| Vomiting | 2 | 1999 | 73 | 0.020 |
Why?
| Virginia | 1 | 2008 | 15 | 0.020 |
Why?
| Biopsy, Fine-Needle | 1 | 2009 | 116 | 0.020 |
Why?
| Flatulence | 1 | 2008 | 4 | 0.020 |
Why?
| Observer Variation | 1 | 2008 | 140 | 0.020 |
Why?
| Linkage Disequilibrium | 1 | 2007 | 48 | 0.020 |
Why?
| Rectum | 1 | 2008 | 55 | 0.020 |
Why?
| Pelvic Floor | 1 | 2008 | 47 | 0.020 |
Why?
| Fathers | 1 | 2007 | 16 | 0.020 |
Why?
| Shoulder Fractures | 1 | 2007 | 10 | 0.020 |
Why?
| Wisconsin | 1 | 2007 | 44 | 0.020 |
Why?
| Pedigree | 1 | 2007 | 134 | 0.020 |
Why?
| Obstetrics and Gynecology Department, Hospital | 1 | 2006 | 5 | 0.020 |
Why?
| Femur | 2 | 2000 | 150 | 0.020 |
Why?
| Adaptation, Psychological | 1 | 2008 | 246 | 0.020 |
Why?
| Heart Failure | 1 | 1992 | 479 | 0.020 |
Why?
| Liver | 2 | 2009 | 1272 | 0.020 |
Why?
| Cytodiagnosis | 1 | 2005 | 42 | 0.020 |
Why?
| Insurance, Liability | 1 | 2005 | 1 | 0.020 |
Why?
| Compensation and Redress | 1 | 2005 | 2 | 0.020 |
Why?
| Registries | 1 | 2008 | 545 | 0.020 |
Why?
| Liability, Legal | 1 | 2005 | 13 | 0.020 |
Why?
| Diagnosis-Related Groups | 1 | 2005 | 26 | 0.020 |
Why?
| Mental Status Schedule | 1 | 2005 | 19 | 0.020 |
Why?
| Washington | 1 | 2005 | 44 | 0.020 |
Why?
| Diastole | 1 | 2005 | 76 | 0.020 |
Why?
| Sex Characteristics | 1 | 2007 | 210 | 0.020 |
Why?
| Cecostomy | 1 | 2004 | 1 | 0.020 |
Why?
| Blood Flow Velocity | 1 | 2005 | 116 | 0.020 |
Why?
| Pain Measurement | 1 | 2006 | 252 | 0.020 |
Why?
| Comorbidity | 1 | 2007 | 676 | 0.020 |
Why?
| Delivery Rooms | 1 | 2004 | 1 | 0.020 |
Why?
| Phenotype | 1 | 2007 | 821 | 0.020 |
Why?
| Suicide | 1 | 2005 | 76 | 0.020 |
Why?
| Wound Infection | 1 | 2004 | 31 | 0.020 |
Why?
| Overweight | 1 | 2006 | 231 | 0.020 |
Why?
| Gram-Positive Bacterial Infections | 1 | 2004 | 35 | 0.020 |
Why?
| Decision Making | 1 | 2006 | 300 | 0.020 |
Why?
| Injury Severity Score | 1 | 2004 | 181 | 0.010 |
Why?
| Fetal Hypoxia | 1 | 2003 | 2 | 0.010 |
Why?
| Polyunsaturated Alkamides | 1 | 2003 | 3 | 0.010 |
Why?
| Resuscitation | 1 | 2003 | 77 | 0.010 |
Why?
| Heparin | 1 | 2004 | 96 | 0.010 |
Why?
| Vancomycin | 1 | 2004 | 90 | 0.010 |
Why?
| Neutrophils | 1 | 2004 | 154 | 0.010 |
Why?
| Fever | 1 | 2004 | 126 | 0.010 |
Why?
| Injections, Intravenous | 1 | 2003 | 148 | 0.010 |
Why?
| Hypothyroidism | 1 | 2003 | 53 | 0.010 |
Why?
| Fibrinolytic Agents | 1 | 2004 | 138 | 0.010 |
Why?
| Organ Size | 1 | 2003 | 250 | 0.010 |
Why?
| Heart Rate | 1 | 2003 | 345 | 0.010 |
Why?
| Analgesics, Opioid | 1 | 2006 | 489 | 0.010 |
Why?
| Asthma | 1 | 2003 | 279 | 0.010 |
Why?
| Karyotyping | 1 | 1999 | 94 | 0.010 |
Why?
| Headache | 1 | 1999 | 80 | 0.010 |
Why?
| Liver Diseases | 1 | 1999 | 85 | 0.010 |
Why?
| Pulse | 1 | 1998 | 20 | 0.010 |
Why?
| Stomach | 1 | 1999 | 76 | 0.010 |
Why?
| Injections | 1 | 1998 | 61 | 0.010 |
Why?
| Mathematics | 1 | 1998 | 47 | 0.010 |
Why?
| Aminohippuric Acids | 1 | 1997 | 1 | 0.010 |
Why?
| Heart Arrest | 1 | 1999 | 143 | 0.010 |
Why?
| Blood | 1 | 1997 | 31 | 0.010 |
Why?
| Acidosis, Respiratory | 1 | 1997 | 2 | 0.010 |
Why?
| Blood Specimen Collection | 1 | 1997 | 39 | 0.010 |
Why?
| Twin Studies as Topic | 1 | 1996 | 3 | 0.010 |
Why?
| Pain | 1 | 1999 | 391 | 0.010 |
Why?
| Inflammation | 1 | 2000 | 646 | 0.010 |
Why?
| Feasibility Studies | 1 | 1997 | 401 | 0.010 |
Why?
| Diagnostic Tests, Routine | 1 | 1995 | 32 | 0.010 |
Why?
| Extraction, Obstetrical | 1 | 1992 | 3 | 0.010 |
Why?
| Nerve Compression Syndromes | 1 | 1992 | 8 | 0.010 |
Why?
| Granulation Tissue | 1 | 1992 | 11 | 0.010 |
Why?
| Anemia, Hemolytic | 1 | 1992 | 11 | 0.010 |
Why?
| Debridement | 1 | 1992 | 53 | 0.010 |
Why?
| Random Allocation | 1 | 1992 | 323 | 0.010 |
Why?
| Syndrome | 1 | 1992 | 249 | 0.010 |
Why?
| Diabetes Mellitus | 1 | 1994 | 287 | 0.010 |
Why?
|
|
Magann's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|